In a remarkable display of strength, McDonald’s (MCD) has exceeded earnings expectations for the third quarter (Q3), bolstered by increased menu prices that drove sales
Alzamend Neuro, a clinical-stage biopharmaceutical company dedicated to advancing innovative treatments for Alzheimer’s disease, bipolar disorder, major depressive disorder, and PTSD, announced today that its
Global network connectivity solutions leader CommScope Holding Company has released preliminary financial results for the quarter (Q3) ending September 30, 2023, indicating a significant downturn
In a significant development for the hearing health industry, Eargo Inc, a prominent medical device company, announced today that it has entered into a definitive
In a monumental move set to reshape the landscape of organ manufacturing, United Therapeutics Corporation and Miromatrix Medical Inc have officially inked a definitive agreement
VYNE Therapeutics, a clinical-stage biopharmaceutical company specializing in innovative therapies for immuno-inflammatory conditions, has announced that it has finalized a securities purchase agreement with select
In a significant move to oversee the burgeoning field of artificial intelligence (AI), President Joe Biden has issued a comprehensive executive order directing the US
After enduring a week of volatility, the US stock market experienced a notable upswing on Monday, with both the Dow Jones Industrial Average (^DJI) and
In a tumultuous conclusion to a challenging week for investors, stocks closed with a mixed performance on Friday. The S&P 500 (^GSPC) officially entered correction